Analyst Reco. Clover Health Investments, Corp.

Equities

CLOV

US18914F1030

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.68 ^USD	+1.49%		+6.99%	-28.58%

Apr. 22	Clover Health Investments, Corp. Announces the Appointment of Peter Kuipers as Chief Financial Officer	CI
Mar. 19	Clover Health Launches New Clinical Program in Partnership with quarter Health to Address Serious Mental Illness	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Citigroup Adjusts Price Target on Clover Health Investments to $1.50 From $1, Maintains Neutral Rating	23-08-11	MT
Canaccord Genuity Adjusts Price Target on Clover Health Investments to $3 From $4, Maintains Buy Rating	23-03-06	MT
Credit Suisse Trims Clover Health Investments' PT to $1.25 From $2.50, Says Multiples Across Tech Managed Care Organization Space Have Compressed; Keeps Underperform Rating	23-03-06	MT
Credit Suisse Trims Clover Health Investments' Price Target to $2.50 From $3, Lowers 2022 to 2024 Revenue Estimatesl; Keeps Underperform Rating	22-11-21	MT
Citigroup Adjusts Price Target on Clover Health Investments to $1.80 From $3.50, Maintains Neutral Rating	22-11-16	MT
SVB Securities Adjusts Price Target on Clover Health Investments to $1.50 From $3, Maintains Market Perform Rating	22-11-08	MT
Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023	22-10-11	GL
Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023	22-10-11	GL
Citigroup Raises Clover Health Investments Price Target to $3.50 From $3, Maintains Neutral Rating	22-08-09	MT
BofA Securities Adjusts Clover Health Investments Price Target to $2 From $2.50, Maintains Underperform Rating	22-06-15	MT
BofA Securities Assess Risks to Managed Care Sector Amid Shifting Regulatory Environment, Market Disruption	22-05-26	MT
SVB Securities Raises Clover Health Investments Price Target to $3 From $2.50, Maintains Market Perform Rating	22-05-10	MT
Canaccord Genuity Starts Clover Health Investments at Buy With $6 Price Target	22-02-02	MT
Cowen Upgrades Clover Health Investments to Market Perform From Underperform, Adjusts Price Target to $3 From $7	22-02-02	MT
SVB Leerink Starts Clover Health Investments at Market Perform With $3 Price Target	22-01-19	MT
Credit Suisse Downgrades Clover Health Investments to Underperform from Neutral, Says Need to Raise Capital Remains; Adjusts PT to $3.50 from $9	22-01-07	MT
Clover Health Investments : PPO Plan Gets Higher Rating From Centers for Medicare and Medicaid Services	21-10-08	MT
CLOVER HEALTH INVESTMENTS : Cowen Initiates Clover Health Investments With Underperform Rating, $7 Price Target	21-09-09	MT
CLOVER HEALTH INVESTMENTS : JPMorgan Downgrades Clover Health Investments to Underweight From Neutral; Price Target is $9	21-07-12	MT
CLOVER HEALTH INVESTMENTS : BofA Securities Downgrades Clover Health Investments to Underperform From Neutral; Price Target is $10	21-06-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Clover Health Investments, Corp.

Equities

CLOV

US18914F1030

Analyst Reco.

Filters